X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (177) 177
gastroenterology & hepatology (134) 134
index medicus (120) 120
male (112) 112
female (110) 110
gastroenterology and hepatology (92) 92
middle aged (92) 92
adult (81) 81
cirrhosis (60) 60
hepatitis c (57) 57
hepatitis c, chronic - drug therapy (51) 51
antiviral agents - therapeutic use (46) 46
biopsy (46) 46
aged (42) 42
fibrosis (42) 42
hepatitis (40) 40
hepatitis c virus (40) 40
hepatitis c, chronic - complications (34) 34
liver cirrhosis - pathology (34) 34
ribavirin (34) 34
chronic hepatitis-c (33) 33
treatment outcome (33) 33
abridged index medicus (32) 32
animals (32) 32
hepacivirus - genetics (32) 32
virus-infection (32) 32
analysis (31) 31
liver cirrhosis - diagnosis (31) 31
care and treatment (30) 30
liver - pathology (30) 30
ribavirin - therapeutic use (30) 30
drug therapy, combination (29) 29
interferon (29) 29
liver (29) 29
genotype (28) 28
health aspects (26) 26
liver cirrhosis (26) 26
article (25) 25
liver diseases (25) 25
antiviral agents - adverse effects (24) 24
hepatitis c, chronic - virology (24) 24
hepatology (24) 24
interferon-alpha - therapeutic use (24) 24
therapy (24) 24
disease progression (22) 22
recombinant proteins (22) 22
liver fibrosis (21) 21
diagnosis (20) 20
plus ribavirin (20) 20
antiviral agents - administration & dosage (19) 19
infection (19) 19
liver cirrhosis - blood (19) 19
prospective studies (19) 19
severity of illness index (19) 19
united-states (19) 19
disease (18) 18
polyethylene glycols - therapeutic use (18) 18
predictive value of tests (18) 18
biomarkers - blood (17) 17
liver cirrhosis - etiology (17) 17
medical colleges (17) 17
medicine & public health (17) 17
hcv (16) 16
infectious diseases (16) 16
liver cirrhosis - virology (16) 16
medicine, general & internal (16) 16
united states (16) 16
young adult (16) 16
clinical trials (15) 15
double-blind method (15) 15
gastroenterology (15) 15
genetic aspects (15) 15
liver cirrhosis - complications (15) 15
prognosis (15) 15
adolescent (14) 14
aged, 80 and over (14) 14
alanine transaminase - blood (14) 14
drug therapy (14) 14
hepatitis c - drug therapy (14) 14
ribavirin - administration & dosage (14) 14
ribavirin - adverse effects (14) 14
sensitivity and specificity (14) 14
sofosbuvir (14) 14
uridine monophosphate - analogs & derivatives (14) 14
genotype & phenotype (13) 13
hepacivirus - drug effects (13) 13
risk factors (13) 13
time factors (13) 13
transient elastography (13) 13
antiviral agents (12) 12
elasticity imaging techniques - methods (12) 12
natural-history (12) 12
viral load (12) 12
aspartate aminotransferases - blood (11) 11
biological response modifiers (11) 11
cohort studies (11) 11
crystallization (11) 11
fatty liver (11) 11
hepatitis b (11) 11
medical research (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9615, pp. 838 - 851
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9865, pp. 468 - 475
Journal Article
Current Gastroenterology Reports, ISSN 1522-8037, 2014, Volume 16, Issue 2
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9883, pp. 2100 - 2107
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 401 - 408
Summary Background Protease inhibitors have improved treatment of infection with hepatitis C virus (HCV), but dosing, a low barrier to resistance, drug... 
Infectious Disease | PSI-7977 | INFECTIOUS DISEASES | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | BOCEPREVIR | INHIBITORS | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Male | Secondary Prevention | Polyethylene Glycols - therapeutic use | Young Adult | Time Factors | Ribavirin - administration & dosage | Adult | Female | Headache - chemically induced | Uridine Monophosphate - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adolescent | Liver Cirrhosis - pathology | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Protease inhibitors | Proteases | Gastrointestinal diseases | Clinical trials | Product development | Genetic aspects | Interferon | Hepatitis C | Health aspects | Liver cirrhosis | Viral antigens
Journal Article
Current Gastroenterology Reports, ISSN 1522-8037, 2/2014, Volume 16, Issue 2, pp. 1 - 7
The evaluation of liver fibrosis is critical, particularly to rule out cirrhosis. Novel non-invasive tests such as transient ultrasound elastography are widely... 
Cirrhosis | Viral hepatitis | Ultrasound elastography | Medicine & Public Health | Gastroenterology | Liver stiffness | Liver fibrosis | Virus diseases | Hepatitis | Medical colleges | Liver cirrhosis
Journal Article
Gastroenterology Clinics of North America, ISSN 0889-8553, 2019, Volume 48, Issue 2, p. 281
All chronic liver disease can lead to liver fibrosis. Assessment of the severity of liver fibrosis is central to making treatment and management decisions.... 
Fibrotest | APRI | NAFLD fibrosis score | FIB-4 | Liver fibrosis | Hepascore | ELF | Fibrosure
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 16, pp. 1483 - 1493
Journal Article